01
Tailored solutions to support early-stage therapy development programs and provide real-world evidence.
Biopharma Solutions
01
Novel marker discovery
Leverage our comprehensive 473-gene panels & more than 20,000 multi-omics profile for biomarker discovery and validation.
02
Asia real-world insights
Identify unmet needs in Asia-population, biomarker prevalence and market size from more than 60,000 Real-World Data.
03
ctDNA monitoring for early-stage solid tumor drug development
Tailored circulating tumor assays as a dynamic biomarker in drug development and clinical trials design, followed with FDA guidance document.
